← Open Payments lookup

ETHAN ITTNER: Open Payments

NPI 1083908248 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,253 in 53 payments from 17 companies in 2025. Trend: 2023 $985 · 2024 $1,239 · 2025 $1,253

Food & beverage: $1,253
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$204
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$182
ABBVIE INC.6$123
Axsome Therapeutics, Inc.5$115
Teva Pharmaceuticals USA, Inc.4$100
Vanda Pharmaceuticals Inc.4$87
Bausch Health US, LLC3$70
Janssen Pharmaceuticals, Inc2$67
Otsuka America Pharmaceutical, Inc.3$58
E.R. Squibb & Sons, L.L.C.3$49

Products named: INGREZZA, CAPLYTA, VRAYLAR, Auvelity, FANAPT, AUSTEDO XR, APLENZIN, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.